Introduction
============

Cutaneous leishmaniasis (CL) is known as an endemic disease in Iran and according to WHO, annually reports, nearly 20000 new cases occur per year in this country. Moreover, some researchers believe that it may be underestimating, and the actual rate is more than this ([@B1], [@B2]).

*Leishmania major* and *L. tropica* are the main cause of zoonotic CL (ZCL) and anthroponotic CL (ACL) in Iran, respectively ([@B3]). CL is reported in 17 out of 31 provinces of Iran and Sistan and Baluchestan is one of the important endemic foci of ACL and ZCL. In recent years, 3 cutaneous leishmainasis foci Chabahar, Konarak, and Mirjaveh were identified in Sistan and Baluchistan Province and CL cases reported progressively from these areas ([@B4]). Moreover, an outbreak of CL happened in Mirjaveh City for the first time in 1996 and this province is considered as a third focus of ZCL ([@B5]).

Differentiation of species is critical, because preventing and controlling methods, clinical course, prognosis and choice of treatment are different from species. Because of the morphological similarities, microscopic examinations are not capable to differentiate the species. Isoenzyme technique is considered as a golden standard method for characterization of especial species. This method requires an abundant number of parasites, is not cost effecting and is time-consuming ([@B6]).

Considering wide clinical spectrum of CL, conventional diagnostic methods such as morphological and parasitical methods are not appropriate methods anymore. In recent years application of high tech molecular methods, such as PCR- RFLP, RAPD-PCR, nested-PCR and Real time PCR are increasing sharply because of their high specificity and sensitivity in detection and identification ([@B7], [@B8]).

ITS, gp63, miniexon, kinetoplastic DNA and HSPs are the available genetic targets for molecular diagnosis of *Leishmania* species ([@B9]). Heat-shock proteins are highly conserved in all organisms. HSPs constitute a large family of proteins that are often categorized based on their molecular weight: hsp10, hsp40, hsp60, hsp70, hsp90*,* etc. ([@B10]). Hsp70 genes are sensitive enough for differentiation of *Leishmania* species. Because of the encoding for a major antigen, allow probing of the genetic variability of molecules and lower rate of genetic variation hsp70 genes are more priority than others ([@B11]). For future multigenic PCR-oriented approaches as well as studies involving direct populations, this new marker can be instrumental ([@B9]).

Sistan and Baluchestan is one of the endemic areas for CL but the species of *Leishmania* were identified. Therefore, the aim of present study was to detect the parasite species using the PCR-RFLP method.

Materials and Methods
=====================

Study Area
----------

The province of Sitan and Baluchestan, is one of the 31 provinces of Iran, located in southeastern Iran, bordering Pakistan and Afghanistan with geographical coordinates between 29.4924°N 60.8669°E ([Fig. 1](#F1){ref-type="fig"}). The capital is Zahedan. The most prominent climatologically phenomenon of the region is the heat. This province is characterized by long, hot and dry summers and short winters, whereas in coastal region, near the Oman Sea, the weather is warm with a high percentage of humidity.

![Map of Sistan and Baluchistan Province, Iran. Districts and geographical outlines are depicted](IJPA-11-489-g001){#F1}

Sample collection
-----------------

In this experimental study, samples were collected from the individuals clinically suspected to CL and referred to Konarak and Chabahar health centers. A questioner was completed to record the essential information such as demographic information, sites of ulcer on the body and travel history.

After obtaining a complete clinical history, finally 130 samples were taken for isolation of *Leishmania* species.

The study was conducted in the laboratory of Zahedan University of Medical Sciences in the Sistan and Baluchestan Province, southeastern Iran in 2015. The study was approved by Ethics Committee of Zahehl University of Medic Sciences.

Samples Preparation
-------------------

Skin suspected lesions were cleaned with 70% ethanol and the samples by injecting 0.2 ml of sterile saline into the dermis of the inside border of skin wounds with 1 ml of sterile insulin syringe were collected. Afterward suction, the serosity was moved to the sterile 1ml tube enclosing the 0.5 ml of ethanol 70%. The tubes were retained in freezer at −20 °C until molecular examination.

Microscopic examination
-----------------------

Direct smears for standard microscopically examination was prepared by aspiration of fluid from under the ulcer. After air-drying, slides were fixed with absolute methanol, stained with Giemsa 10%, and observed via optical microscopy (magnification ×1000) for the existence of amastigote forms of the parasite.

DNA extraction
--------------

DNA was extracted from Geimsa stained slides as declared by the manufacturer using the High Pure PCR Template Purification (Takapouzist, Iran DynaBio Blood/Tissue Genomic DNA Extraction Kit). The extracted DNA was stored at −20 °C until use.

PCR of the HSP70 gene
---------------------

To detect and identification of the *Leishmania* species isolates, we used the HSP70 region, using the primers 70-IR-D (5′- CCAAGGTCGAGGAGGTCGAC TA- 3′) and 70-IR-M (5′- ACGGGTAGGG GGAGGAAAGA -3′) ([@B12]). Amplification was done in 30 ml containing 3 ml of PCR buffer (Roche, Mannheim, Germany), 2.5 mM MgCl2 (25 mM; Roche), 1 ml Dntp (10 mM; Roche), 15 pMol of each primer, 10 ng of genomic DNA and 0.5 units of Taq polymerase (GeNet Bio, Korea). Amplification was done with 35 cycles, each of 30 s at 94 °C, 30-s at 49 °C, and 1 min at 72 °C in a thermocycler (Biometra, Goettingen, Germany). Then 5 mL of each PCR reaction was run on a 1% agarose gel and stained with ethidium bromide. Finally, reactions producing a product of about 750 bp were considered positive.

Insilico-RFLP for positions and RFLP of HSP 70 PCR products
-----------------------------------------------------------

The PCR product including the amplified HSP70 were digested with HaeIII (BsuR1) (Fermentas, Life Sciences, Germany) as commended by the producer. Digestion products were separated using 3% agarose gels in TAE buffer and visualized after staining by gel red.

Using software of CLCDNA in the insilico analysis and using Fasta format genes downloaded from GenBank and with BsuR1 enzymes, the number of regions in different species was identified. In HSP70 genes in the *L. major* using Bsur1enzymes and three sections and four sizes 70, 178, 183 and 323 bp were provided. Besides, *L. tropica* HSP70 gene was examined and two sections and three pieces with sizes 182, 243, 321bp were delivered.

DNA sequencing
--------------

PCR products of HSP70 from five isolates, 2 samples from *L. tropica* and three samples from *L. major* were purified from the agarose gel, by PCR purification kit (Bioneer, Korea), and sequenced from both directions (Applied Biosystems, DNA Analyzers Sequencing, Bioneer, Korea, Sanger method), using the same primers used in PCR. Multiple alignments were performed with data related to *Leishmania* spp. from Iran and other countries deposited in GenBank using BioEdit Sequence Alignment Editor Vr. 7.2.5 software. A Neighbor-Joining tree was constructed using MEGA6 software. Bootstrap analyses (using 1,000 replicates) were carried out to define the robustness of the finding.

Results
=======

Suspected CL patients samples were microscopically surveyed at first. Out of 130 suspected patients, 59 (45.3%) were positive by the microscopic examination. DNA was extracted from all patients and 64 (49.2%) samples were positive. Twenty-four (37.5%) patients were from Konarak City and 40 (62.5%) were from Chabahar city ([Fig. 2](#F2){ref-type="fig"}) by PCR technique with HSP70 gene. For RFLP-PCR method, PCR products were digested by HAEIII as the restriction enzyme. The results of RFLP-PCR method indicated that 53 (82.8%) of samples patterns were identical to that of *L. tropica* and 11 (17.1%) to that of *L. major* ([Fig. 3](#F3){ref-type="fig"}). The results of phylogenetic analysis of this study are shown in [figure 4](#F4){ref-type="fig"}. Multiple lesions were seen in ZCL forms due to *L. major* and most ulcers were in hands and feet. However, ACL due to *L. tropica* usually accompanied with one lesion in face. The predominant species in these areas was *L. tropica.*
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![Phylogenetic relationship of HSP70 sequences of isolates of *L.tropica* and *L.major* from Iran using Neighbor-Joining method. *Plasmodium berghei* (AN: L40815) was used as the out group](IJPA-11-489-g004){#F4}

Discussion
==========

Leishmaniasis is an important parasitic disease that is life threating for human in endemic areas ([@B13]). Cutaneous leishmaniasis is the most prevalent dermatological disease worldwide and considered as one of the challenging health problem in involved countries ([@B14]).

Afghanistan, Iran, Syria, Saudi Arabia, Algeria, Brazil and Peru are containing more than 90% of CL new cases, which occur annually ([@B15]). Iran is one of the endemic areas for CL so that in more than half of the population are at risk ([@B16]) and 20--40/100,000 cases are annually reported ([@B17], [@B18]). ACL (dry or urban) and ZCL (wet or rural) are two common forms of cutaneous leishmaniasis in Iran ([@B19]). Because of the different strategies of prevention and control, identification of the species is crucial ([@B20]).

CL has been emerged in recent years in Konark and Chabahar, Sistan and Baluchestan areas in southeast of Iran. These border regions have geographically important because of the business, tourism industry and exchanging visitors from neighboring countries. CL is an emerging disease in these areas, the main cause specie was not distinguished up to now, and medical doctors have relied on the clinical manifestations whereas the clinical symptoms are variable and may be confused with other etiological causes ([@B20]). Molecular-based techniques are valuable for identification of the species of *Leishmania* ([@B21]). PCR has been used widely for detection of infection, and identification of *Leishmania* species in CL, visceral leishmaniasis and other forms of the disease ([@B22]--[@B24]).

Phylogenetic studies in *Leishmania* needs more focusing on molecular markers; for this purpose (ITS) 1 and 2, cytochrome oxidase II gene, glycoprotein 63 gene, cysteine protease B genes, cytochrome B gene, heat shock protein genes and suchlike have been used for analyzing phylogenetic issues in *Leishmania*. ([@B25]).

Heat shock proteins (HSPs) are likely to play important roles in the differentiation of the promastigotes in sandflies from to amastigotes in mammalian hosts ([@B26]--[@B28]). HSPs, which seem to be implicated in the adaptation and survival of the cell to heat and other stress conditions ([@B29]). Among HSPs, HSP70 is the most highly conserved in sequence and function in all organisms ([@B30]). Fraga et al. introduced an important and novel technique for identification of *Leishmania* species with sequencing of HSP70 regions ([@B31]). They are the best-conserved sequences along the evolutionary tree of life ([@B32]). The HSP70 gene is being widely used as a target for PCR-RFLP assays for *Leishmania* species differentiation because of its lower rate of genetic diversity than other markers for instance *gp63* or rDNA ITS genes ([@B9], [@B33]).

In several provinces of Iran CL is reported and to identification of the leishmaniasis species in several studies different laboratory methods have been performed ([@B34], [@B35]). In Mashhad Province, using ITS-PCR and PCRRFLP, the dominant causative agent of CL was *L. tropica* ([@B36]--[@B38]). In Shush City in Khuzestan and in Shiraz Province by Nested PCR, the dominant species was *L. major* ([@B35], [@B39]).

In several studies, the molecular methods were used to identify *Leishmania* species in the patients, vectors and reservoirs. In Brazil recognition of *Leishmania* parasites showed PCR-RFLP profiling of the hsp70 gene as a valuable tool for recognizing *Leishmania* species related with human leishmaniasis ([@B33]). In Japan, *Leishmania* species was identified in the sand flies using PCR ([@B40]). In Spain, detection of *Leishmania* parasite in biopsies from 100 dogs using PCR was shown that in 63% of the dogs, *Leishmania* DNA could be detected by PCR in at least in one of the tissues studied ([@B41]). In France, *Leishmania* species was identified in the mouse tissues using Real-Time PCR ([@B42]).

For identification of *Leishmania* species isolates from Konark and Chabahar, Sistan and Baluchestan Province, we used HSP-70 as an ideal object for classification of different *Leishmania* species through the PCR-RFLP method. This method has been applied and showed to be valuable for diagnosis and identification of *Leishmania* ([@B9], [@B12], [@B31], [@B33], [@B43]--[@B46]).

In the current study, from 130 suspected CL patients infected, 59 (45.3%) were positive by the microscopic examination while using HSP70-PCR 64(49.2%) samples were positive. In a study, from 155 suspected CL patients, 69 (44.5%) cases were positive by microscopic examination and 86 (55.4%) were positive by ITS-PCR ([@B47]).

According to similar study conducted on samples from different parts of Iran, *L. major* is the most important causative agent of CL in Khuzestan, Ilam, Kermanshah and Semnan, however ([@B48]). *L. tropica* is reported from Kurdistan Province as the major cause of CL. Our study showed similar results; in Tehran, North Khurasan, Esfahan, Kerman, Fars and Razavi Khurasan both *L. tropica* and *L. major* were identified ([@B48]).

Additionally, there is not any report of *L. aethiopica*, *L. Mexicana* complex and *L. braziliensis* complex in human ([@B48]--[@B50]). Nevertheless in this area of study to identify the species of *Leishmania* parasite limited molecular approaches was carried out and there is not correct map for this issue so this study was conducted as a pilot.

Conclusion
==========

PCR-RFLP is a valuable technique for distinguish of *Leishmania* species. Furthermore, Sistan and Baluchestan is one of the important foci of ACL and also ZCL and unlike to other study in these area, ACL is the dominant cause of CL. Free trading area, immigrants from Pakistan and Afghanistan country, Kerman and Yazd provinces (foci of ACL); are some reasons that *L. tropica* is the dominant species. Additionally, dogs as a reservoir hosts *Phlebotomus sergenti* as a most prevalent sand fly in these areas are helping *L. tropica* to be a dominant species.

Meanwhile *L. tropica* (the dominant species.) is an anthroponotic parasite, therefore in order to control the disease, it is suggested to focus on chemotherapy of patients and for *L. major* should have to pay more attention on immigrants from rural areas and visitors from neighboring countries (Pakistan and Afghanistan) and rodents eradication.
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